Scientific experiments drive token economy: Can $RIFSOL become the next unicorn?
远山洞见2024/11/19 10:23
By:远山洞见
I. Project introduction
$RIFSOL is a Meme coin based on the concept of antibiotic Rifampicin. It is published by the Pump.Science platform Molecular DAO launched by the Solana ecological DeSci project. As an important attempt of the decentralized science (DeSci) concept, $RIFSOL combines token economy with antibiotic research and longevity technology, providing a decentralized solution for traditional scientific research funding.
Pump.Science platform's unique experiment-driven mechanism allows the community to directly participate in scientific research funding. When the market value of tokens such as $RIFSOL reaches the experimental threshold, the platform funds will be invested in relevant drug research and the trial results will be made public. This Gamification research funding model not only subverts traditional methods, but also greatly enhances the transparency and public participation of scientific research.
Currently, the market value of $RIFSOL has exceeded 87.90 million USD, becoming the leading Meme project in the DeSci sector. In the wave of decentralized technology driving scientific research, $RIFSOL and Pump.Science platforms are becoming an undeniable innovative force, injecting more possibilities into scientific storytelling.
Ⅱ.Narrative Description
$RIFSOL is a Meme coin designed around the antibiotic Rifampicin, which was born on the Pump.Science platform. Its goal is clear: to support medical research in a decentralized way. Players promote market value growth by trading tokens. When the market value reaches the experimental threshold, the platform will invest funds in related drug research and regularly disclose the trial results. This model allows scientific research to no longer be limited to traditional funding channels, and participants can more directly support and observe the progress of medical experiments.
As a decentralized science platform launched by Molecular DAO, Pump.Science combines token trading with actual scientific research to create a new funding mechanism. Through $RIFSOL, the community can not only support antibiotic research, but also evaluate drug efficacy through public trial data, further optimizing market trading decisions. The combination of research and community participation creates a unique linkage between experiments and tokens.
In the trend of decentralized science (DeSci), the emergence of $RIFSOL provides a new attempt. It is not only a tokenized tool for antibiotic research, but also an experiment to make scientific research transparent and decentralized. Through this form, scientific research and market transactions are closely linked, exploring new possibilities for the integration of science and blockchain technology.
III. Market value expectations
Currently, $RIFSOL has become an innovative benchmark in the DeSci sector, with a market value significantly higher than the early project Data Lake, but similar to VitaDAO's target audience and narrative. If market sentiment and narrative further drive it, $RIFSOL has the opportunity to challenge higher valuation levels.
$RIFSOL Current unit price: 0.153 dollars
Market capitalization: $153M
Total supply: 999.7M
Benchmark project type and market value expectations:
1. VitaDAO ($VITA) - A DAO collective that funds longevity research
Unit price: 5.23 dollars
Market capitalization: $134.84M
If the circulating market value of $RIFSOL reaches the level of $VITA, the token unit price is about 0.135 dollars
2. Data Lake ($LAKE) - A blockchain-based medical data donation system
Unit price: 0.0179 dollars
Market capitalization: $24.04M
If the circulating market value of $RIFSOL reaches the level of $LAKE, the token unit price is about 0.024 dollars
IV. Economic models and on-chain chip analysis
According to GMGN.AI on-chain data, the current market cap of $RIFSOL is $152M, and the circulation accounts for 20.7% of the total supply. The total supply is 999.7M.
The total liquidity of the token is $3.8M (equivalent to about 7,718.53 SOL), and the pool funds are mainly concentrated in Raydium, Coinbase, and Bitget. The design of $RIFSOL revolves around the medical experiments and research support of the Pump.Science platform, and the token trading is directly linked to the progress of the experiment. After the market value of the token reaches the experimental threshold, drug research experiments will be launched. This mechanism makes $RIFSOL not only a trading tool, but also undertakes the function of supporting antibiotics and longevity research, truly realizing the combination of scientific and economic models. In addition, the transparent disclosure of experimental results also provides token holders with feedback on the scientific experimental effects, which helps the market to further price the token.
Currently, the number of holding addresses for $RIFSOL is 26.6K, and the holding ratio of Top 10 addresses is 11.3%, showing a relatively dispersed token distribution. The largest single address holder (AcUm7... LRA) holds 2%, worth about $3.1M, which is currently the largest single address holding ratio. This position distribution indicates a high degree of decentralization of the project, reducing the control risk of a single large holder in the market while maintaining good market participation.
The participation of centralized exchanges is obvious, such as Bitget and MEXC holding 1.8% and 0.76% respectively. Although the holding ratio of these exchanges is not high, it indicates that the publishing and trading of tokens have been paid attention to by mainstream trading platforms, further enhancing the liquidity of the market and the popularity of tokens. Especially with Bitget's strong intervention, it has expanded more potential markets for token user distribution.
Recent on-chain data shows that a small number of large account addresses are still absorbing funds, reflecting the continuous increase in market recognition of $RIFSOL. However, it is worth noting that some addresses have short-term arbitrage behavior, such as the associated addresses of high-frequency exchanges Coinbase and Binance, which may affect the short-term volatility of tokens. In addition, some addresses with smaller positions are also diversifying their holdings, which may be a manifestation of early investors cashing out their profits.
V. Risk Warning
1. Although the Pump.Science platform promises to make the results of the experiment public, scientific research itself is highly uncertain. Failure of the experiment or results that are not as expected may weaken community confidence and further exacerbate token price fluctuations.
2. Although the current holding addresses of $RIFSOL are relatively scattered, there are still significant holding ratios in some large account addresses. These large holders may have significant voice over in the market. Once a concentrated selling or arbitrage occurs, it will have a severe impact on the token market price.
VI. Official links
website:https://happycatonsol.com/
Twitter:https://www.pump.science/
Telegram:https://t.me/pump_science
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
PoolX: Locked for new tokens.
APR up to 10%. Always on, always get airdrop.
Lock now!
You may also like
Bitcoin metric breakout teases 'inevitable' 90% BTC price rally next
Cointelegraph•2024/11/19 09:33
MicroStrategy Buys Another 51 Bitcoins for $780 Billion
HappyCoinNews•2024/11/19 08:22
Trending news
MoreCrypto prices
MoreBitcoin
BTC
$92,442.73
+2.09%
Ethereum
ETH
$3,147.81
+2.40%
Tether USDt
USDT
$1
+0.05%
Solana
SOL
$246.14
+1.32%
BNB
BNB
$621.36
+0.90%
XRP
XRP
$1.12
-0.94%
Dogecoin
DOGE
$0.3881
+7.03%
USDC
USDC
$0.9999
-0.00%
Cardano
ADA
$0.7487
+2.16%
TRON
TRX
$0.2052
+1.95%
Bitget pre-market
Buy or sell coins before they are listed, including ZRC, MAJOR, OGC, MEMEFI, and more.
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new Bitgetters!
Sign up now